EP4326361A1 - Verfahren zum steuern einer blutbehandlungsvorrichtung, und vorrichtungen - Google Patents
Verfahren zum steuern einer blutbehandlungsvorrichtung, und vorrichtungenInfo
- Publication number
- EP4326361A1 EP4326361A1 EP22724073.6A EP22724073A EP4326361A1 EP 4326361 A1 EP4326361 A1 EP 4326361A1 EP 22724073 A EP22724073 A EP 22724073A EP 4326361 A1 EP4326361 A1 EP 4326361A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- blood
- treatment device
- pump
- blood treatment
- transmembrane pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 185
- 210000004369 blood Anatomy 0.000 title claims abstract description 185
- 238000000034 method Methods 0.000 title claims abstract description 71
- 238000004590 computer program Methods 0.000 claims abstract description 20
- 230000001105 regulatory effect Effects 0.000 claims description 24
- 239000000385 dialysis solution Substances 0.000 claims description 20
- 238000000926 separation method Methods 0.000 claims description 18
- 239000012528 membrane Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 14
- 238000000502 dialysis Methods 0.000 claims description 11
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 230000001276 controlling effect Effects 0.000 claims description 8
- 238000001631 haemodialysis Methods 0.000 claims description 7
- 230000000322 hemodialysis Effects 0.000 claims description 7
- 238000002615 hemofiltration Methods 0.000 claims description 5
- 238000005086 pumping Methods 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 2
- 230000001960 triggered effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 7
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 3
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 206010001526 Air embolism Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
- A61M1/36226—Constructional details of cassettes, e.g. specific details on material or shape
- A61M1/362263—Details of incorporated filters
- A61M1/362264—Details of incorporated filters the filter being a blood filter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3626—Gas bubble detectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3629—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters degassing by changing pump speed, e.g. during priming
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
- A61M60/109—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems
- A61M60/113—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems in other functional devices, e.g. dialysers or heart-lung machines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/247—Positive displacement blood pumps
- A61M60/253—Positive displacement blood pumps including a displacement member directly acting on the blood
- A61M60/268—Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders
- A61M60/279—Peristaltic pumps, e.g. roller pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
- A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
- A61M60/37—Haemodialysis, haemofiltration or diafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3334—Measuring or controlling the flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/70—General characteristics of the apparatus with testing or calibration facilities
- A61M2205/702—General characteristics of the apparatus with testing or calibration facilities automatically during use
Definitions
- the present invention relates to a method for controlling a blood treatment device according to claim 1, a control or regulating device according to claim 9 and a blood treatment device according to claim 10.
- the present invention also relates to a digital storage medium according to claim 15, a computer program product according to claim 16 and a computer program according to claim 17 or according to the preambles or generic terms of these claims.
- Various types of blood treatment devices are known from practice. They include, for example, devices for hemodialysis, hemofiltration and hemodiafiltration.
- the blood flows through a blood treatment unit in an extracorporeal blood circuit.
- the blood treatment unit is a dialyzer or filter which, to put it simply, is separated into a blood chamber and a dialysis fluid chamber by a semi-permeable membrane.
- the blood flows through the blood chamber while a dialysis fluid flows through the dialysis fluid chamber.
- Air or microbubbles in extracorporeal circuits downstream of a venous air separating chamber can lead to gas embolism in the patient's body. Embolism can block vessels and cause ischemia.
- the venous air separation chamber is located in the venous blood tubing system. It partially reduces the flow rate within the extracorporeal circuit, so that gas bubbles rise counter to gravity according to the Archimedean principle and can be separated through an opening in an upper area of the venous air separation chamber.
- the venous system downstream of the air separation chamber is checked for the presence of air, e.g. B. in the form of microbubbles, monitored in the extracorporeal flowing blood. If the sensor detects the presence of air, an air bubble alarm will sound, interrupting the patient's blood treatment. After the responsible person has eliminated the cause of the air bubble alarm, the blood treatment can be continued.
- air e.g. B. in the form of microbubbles
- a control or regulating device (in short: control device that can optionally also regulate) is to be proposed with which the method can be brought about or initiated or carried out.
- further devices suitable for carrying out the method in particular a blood treatment device, a digital storage medium, a computer program product and a computer program.
- the object according to the invention is achieved by the method with the features of claim 1. It is also achieved by means of the control or regulating device with the features of claim 9, the blood treatment device with the features of claim 10, by means of the digital storage medium with the features of claim 15, the computer program product with the features of claim 16 and the computer program with the features of claim 17.
- a method for controlling a blood treatment device having a blood pump, an air bubble detector and a pump for conveying dialysis liquid and/or dialysate on its hydraulic side.
- the method is initiated or performed during an extracorporeal blood treatment session, during which the blood treatment device is connected to an extracorporeal blood circuit and to a blood filter, which in turn has a semi-permeable membrane.
- the method includes, for. B. after detecting air bubbles or air pockets in the extracorporeal blood circuit, or z. B. after an air bubble alarm, stopping the blood pump or reducing its output provided immediately before detecting the air bubbles, and generating a negative transmembrane pressure across the semi-permeable membrane of the blood filter away.
- This negative transmembrane pressure can be achieved by appropriately controlling the pump on the hydraulic side while the blood pump is stopped or its delivery rate is reduced.
- the transmembrane pressure can be measured in a variety of ways and its existence can be determined directly or indirectly.
- Air bubbles or air inclusions in the extracorporeal blood circuit can be detected using the air bubble detector.
- the air bubble detector can be suitable or configured to trigger an air bubble alarm (alternatively: gas alarm) as a result of the detection of gas, air or air bubbles, which in turn causes the method according to the invention to be initiated or carried out.
- an air bubble alarm alternatively: gas alarm
- Air bubbles or air inclusions can be detected, for example, by an air bubble alarm, by the fulfillment of conditions that trigger an air bubble alarm or are sufficient to trigger an air bubble alarm.
- a control or regulating device is also proposed, which is configured to initiate, carry out, control and/or regulate the method according to the invention—in particular automatically—in cooperation with a blood treatment device or its facilities or devices, in particular as disclosed herein .
- Interaction can be or include driving, controlling or regulating.
- Interaction may be or require a signal connection.
- a blood treatment device which in each case has at least one blood pump, an air bubble detector, a pump for conveying dialysis fluid and/or dialysate and a control or regulating device, in particular a control or regulating device according to the invention, which in turn is configured to cause a method according to the invention to be carried out is, has or is connected to such inputs and devices in each case.
- the blood treatment device according to the invention can have a correspondingly suitable and/or configured facility or device such as a Legs
- An inventive, in particular digital, in particular non-volatile, storage medium (here also referred to as a carrier), in particular in the form of a diskette, RAM, ROM, CD, hard drive, DVD, USB stick, flash card, SD card or EPROM, in particular with electronically or optically readable control signals, can be configured in such a way in order to configure a control device to form a control or regulating device with which the method according to the invention described herein can be initiated or carried out.
- the digital Storage medium can be configured to configure a blood treatment device to form a blood treatment device according to the invention, with which the method according to the invention described herein can be effected or executed.
- a computer program product according to the invention has a program code that is volatile or stored on a machine-readable carrier, by means of which a control device is configured into a control or regulating device, by means of which the method according to the invention described herein can be initiated or carried out.
- a blood treatment device can be configured by means of the computer program product in such a way that the method according to the invention described herein can be effected or executed.
- machine-readable medium refers to a medium that contains data or information that can be interpreted by software and/or hardware.
- the medium can be a data carrier such as a floppy disk, a CD, DVD , a USB stick, a flash card, an SD card, an EPROM and the like.
- a computer program according to the invention has a program code through which a control or
- Control device or a blood treatment device is configured in such a way that the method according to the invention described herein can be initiated or carried out.
- a computer program product can be, for example, a computer program stored on a carrier, an embedded system as a comprehensive system with a computer program (e.g. an electronic device with a computer program), a network of computer-implemented computer programs (e.g. client/server system , cloud computing system, etc.) or a computer on which a computer program is loaded, run, stored, executed or developed.
- a computer program stored on a carrier
- an embedded system as a comprehensive system with a computer program
- a network of computer-implemented computer programs e.g. client/server system , cloud computing system, etc.
- a computer program can be understood, for example, as a physical, salable software product which has a program.
- a venous air separation chamber or an air separation chamber can also be a venous blood chamber, a venous bladder chamber or a venous drip chamber.
- the subject matter of the invention comprises one or more features in a particular embodiment
- the subject matter according to the invention expressly does not have this or these features in other embodiments that are also according to the invention, e.g. B. in the sense of a disclaimer.
- the contrary embodiment for example formulated as a negation, is also disclosed.
- Embodiments according to the invention can have one or more of the features mentioned above and/or below in any technically possible combination.
- a negative transmembrane pressure is generated across the semi-permeable membrane with the venous tube clamp fully or partially closed.
- the method comprises, as a further step, opening the venous hose clamp when a negative transmembrane pressure has already been generated or is present, while maintaining a negative transmembrane pressure.
- Plasma water transfer takes place and the blood in the dialyzer is hemoconcentrated.
- the fluid volume pumped into the hydraulic system or shifted from the extracorporeal blood circuit to the hydraulic side via the semi-permeable membrane due to the pressure difference is replaced by blood that is counter to (herein also: retrograde) its usual direction of flow within the blood circuit via the venous part of the tubing system from the latter and from the vascular system of the patient is caused to flow by the hemoconcentration and the negative pressure.
- the air bubbles or air inclusions (e.g. gas and micro-bubbles) in the line are transported back retrograde into the venous air separation chamber and separated there, mostly to the environment.
- the venous tube clamp is opened when a pressure sensor of the blood treatment device has determined that a negative minimum transmembrane pressure has been reached.
- a negative transmembrane pressure is generated by the pump on the hydraulic side of the blood treatment device, while an optional substituate pump of the blood treatment device is stopped or not pumping.
- the creation or maintenance of the negative transmembrane pressure is terminated as soon as a negative transmembrane pressure of about
- the conveying by means of the pump on the hydraulic side of the blood treatment device for generating a negative transmembrane pressure is terminated after the air bubble detector no air bubbles or Air inclusions are no longer detected and/or there is no longer an air bubble alarm and/or at least 30 to 60 ml of blood has been pumped retrograde.
- the pump for delivering dialysis liquid and/or dialysate is an optionally provided ultrafiltration pump.
- the blood treatment device according to the invention is connected to an extracorporeal blood circuit and a blood filter, the blood filter having a semi-permeable membrane.
- the extracorporeal blood circuit is a blood tubing set and/or a blood cassette or has a blood tubing set and/or a blood cassette.
- the pump for conveying dialysis liquid and/or dialysate is an ultrafiltration pump.
- the blood treatment device is designed as a hemodialysis device, hemofiltration device,
- Hemodiafiltration device or as a device for performing a separation process.
- this includes determining whether the generated negative transmembrane pressure or its amount is within predetermined limits, exceeds or falls below a limit value, a minimum value exceeds and/or does not exceed a maximum value. This can be done based on at least one criterion (limit, range, maximum, etc.), which z. B. can be stored in a storage device, such as the blood treatment device.
- the method includes only emitting or outputting an acoustic and/or optical or other signal-based air bubble alarm if, during or after the process according to the invention, there is still or again a state that already gave rise to an air bubble alarm before the start of the method according to the invention for the responsible person and/or the blood treatment device. Provision can thus be made for the user to be informed optically and/or acoustically about the presence of an air bubble alarm and/or to only interrupt the blood treatment automatically if, after detecting air bubbles, the removal of the detected air by means of the method according to the invention e.g. B. according to the features of claim 1, was not successful.
- the pump is a displacement pump, in particular a diaphragm pump, eccentric diaphragm pump, peristaltic pump, roller pump or piston pump.
- the extracorporeal blood circuit has no venous air separation chamber, which upside down or inverted, or in which a narrower (or smaller diameter or cross-sectional area) end of the air separating chamber is higher than a larger (or larger diameter or cross-sectional area) end thereof.
- the application of the negative transmembrane pressure is not intended to remove air bubbles directly from the air separating chamber and thus from the extracorporeal blood circuit, bypassing the blood filter.
- the method is not a method of draining an extracorporeal blood treatment device.
- the negative transmembrane pressure is applied while the blood pump is stopped and/or not pumping.
- Another advantage of the present invention may be that the patient does not lose blood by discarding whole blood, e.g. B. in the aforementioned saline bag suffers. This also advantageously contributes to patient well-being and patient safety.
- a fully automated and hygienically an method for treating air bubble alarms in the venous line with induced separation of the microbubbles can be made available. This can advantageously help to reduce personnel costs and increase patient safety.
- Fig. 1 shows a schematically simplified one
- Fig. 2 shows a part of the schematically simplified
- Fig. 3 shows, in a schematically simplified manner, the course of the method according to the invention.
- Fig. 1 shows a schematically simplified fluid line structure of a blood treatment device 100 according to the invention in a first embodiment.
- the blood treatment device 100 is connected to an extracorporeal blood circuit 300, which can be used for treatment by means of double-needle access, or using z.
- an additional Y-connector (reference symbol Y) as shown in Fig. 1 can be connected by means of single-needle access to the vascular system of the patient, not shown.
- the blood circuit 300 can optionally be present in portions thereof in or on a blood cassette. Pumps, actuators and/or valves in the area of the blood circuit 300 can be connected to the blood treatment device 100 according to the invention or to one of these, e.g. B. included control or regulating device 150 connected.
- the blood circuit 300 has an arterial hose clamp or patient hose clamp 302 as a first hose clamp and an arterial connection needle of an arterial section or an arterial patient line, an arterial line section, a blood sampling line or the first line 301 (or is connected to it).
- the blood circuit 300 further comprises (or is connected to) a venous hose clamp or patient hose clamp 306 as a second hose clamp and a venous connection needle of a venous section, a venous patient line, a venous line section, a blood return line or second line 305 .
- a blood pump 101 is provided in or on the first line 301, a substituate pump 111 is connected to a dialysis fluid supply line 104 for conveying fresh dialysis fluid, which is filtered (substituate) in a further filter stage (F2).
- a substituate line 105 may be fluidly connected to the inflow line 104 .
- substituate can be introduced by pre-dilution, via a pre-dilution valve 107, or by post-dilution, via a post-dilution valve 109, via associated lines 107a or 109a into line sections, for example into the arterial line section 301 or into the venous line section 305 (here between a Blood chamber 303b of a blood filter 303 and a venous Air separation chamber of the blood circuit 300) are introduced.
- the blood filter 303 has the blood chamber 303b connected to the arterial line section 301 and to the venous line section 305 .
- Dialysis fluid chamber 303a of the blood filter 303 is connected to the dialysis fluid inlet line 104 leading to the dialysis fluid chamber 303a and a dialysate outlet line 102 leading away from the dialysis fluid chamber 303a and carrying dialysate, ie used dialysis fluid.
- Dialysis fluid chamber 303a and blood chamber 303b are separated from one another by a mostly semi-permeable membrane 303c. It represents the separating sheath between the blood side with the extracorporeal blood circuit 300 and the machine side with the dialysis liquid or dialysate circuit, which is shown on the left of the membrane 303c in FIG.
- FIG. 1 includes an air bubble detector 315 for detecting air and/or blood, preferably in the venous line section 305, e.g. B. at the location shown.
- FIG. 1 optionally also includes one or two pressure sensors PSI (upstream of the blood pump 101) and PS2 (downstream of the blood pump 101, it measures the pressure upstream of the blood filter 303 ("pre-hemofilter")) at the locations shown in Fig. 1.
- Further pressure sensors can be provided, e.g. the pressure sensor PS3 downstream of the venous air separation chamber 329.
- An optional single-needle chamber 317 is used in FIG. 1 as a buffer and/or compensation container in a single-needle method, in which the patient is connected to the extracorporeal blood circuit 300 by only one of the two blood lines 301, 305 .
- the arrangement of Figure 1 also includes an optional detector 319 for detecting air bubbles and/or blood.
- An addition point 325 for heparin can optionally be provided.
- An optional mixing device 163 is shown on the left in Fig. 1, which from the containers A (for A concentrate via the concentrate supply 166) and B (for B concentrate via the concentrate supply 168) a predetermined mixture for the respective solution for use by the blood treatment device 100 provides.
- the solution contains water from the water source 155 (online, e.g. as reverse osmosis water or from bags), which e.g. B. in the heater 162 is heated.
- a pump 171 which may be referred to as a concentrate pump or sodium pump, may be fluidly connected to and/or pump, if provided, from the mixer 163 and a source of sodium, such as container A.
- An optional pump 173 associated with container B, such as for bicarbonate, can be seen.
- a drain 153 for the effluent can also be seen in FIG. 1 .
- An optional heat exchanger 157 and a first flow pump 159 suitable for degassing complete the arrangement shown.
- the optional pressure sensor PS4 downstream of the blood filter 303 on the water side but preferably upstream of the ultrafiltration pump 131 in the dialysate discharge line 102 can be provided for measuring the filtrate pressure or membrane pressure of the blood filter 303.
- Blood leaving the blood filter 303 flows through a venous air separation chamber 329, which is a
- venting device 318 can be in fluid communication with the pressure sensor PS3.
- the exemplary arrangement shown in FIG. 1 has the control or regulating device 150 . It can be in a wired or wireless signal connection with any of the components mentioned here—at least or in particular with the blood pump 101—for controlling or regulating the blood treatment device 100 .
- the optional device for online mixing of the dialysis fluid it is possible to vary its sodium content within certain limits, controlled by the control or regulating device 150 .
- the measured values determined by means of conductivity sensors 163a, 163b can be included for this purpose. Should there be an adjustment the sodium content of the dialysis fluid
- the blood treatment device 100 includes means for conveying fresh dialysis fluid and dialysate on the so-called hydraulic side of the blood treatment device 100.
- a first valve can be provided between the first flow pump 159 and the blood filter 303, which opens or closes the inlet to the blood filter 303 on the inlet side.
- a second, optional flow pump 169 is z. B. provided downstream of the blood filter 303, which promotes dialysate to the drain 153.
- a second valve can be provided between the blood filter 303 and the second flow pump 169, which opens or closes the outlet on the outlet side.
- the blood treatment device 100 optionally includes a device 161 for balancing the flow flowing into and out of the dialyzer 303 on the machine side.
- the device 161 for balancing is preferably arranged in a line area between the first flow pump 159 and the second flow pump 169 .
- the blood treatment device 100 further comprises means for the exact removal of a volume of liquid specified by the user and/or by the control or regulating device 150 from the balanced circuit, such as the ultrafiltration pump 131.
- Sensors such as the optional conductivity sensors 163a, 163b are used to determine the conductivity, which is temperature-compensated in some embodiments, and the liquid flow upstream and downstream of the dialyzer 303.
- Temperature sensors 165a, 165b can be provided individually or in groups. According to the invention, temperature values supplied by them can be used to determine a temperature-compensated conductivity.
- An optional compressed air source 175, for example in the form of a compressor, can be provided on the machine side upstream of the blood filter 303.
- a leakage sensor 167 is optionally provided. Alternatively, it can also be provided elsewhere.
- V in FIG. Bypass valves are marked with VB.
- control or regulating device 150 determines the electrolyte and/or liquid balance based on the measured values of the aforementioned, optional sensors.
- Filter F1 and F2 can be connected in series.
- the filter F1 is used here, for example, by means of the mixing device 163 itself using non-pure Water to produce sufficiently pure dialysis fluid, which then z. B. in the countercurrent principle, through the blood filter 303 flows.
- the filter F2 is used here, for example, to remove, by filtering z. B. pyrogenic substances to generate sterile or sufficiently filtered substituate, which can safely be fed to the extracorporeal flowing blood of the patient and thus ultimately the patient's body.
- the blood treatment device 100 shown in FIG. 1 may be a hemofiltration device, a hemodiafiltration device, or a hemodialysis device.
- the present invention is not limited to the embodiment described above, which is merely illustrative.
- Figure 1 generally indicate the direction of flow in Figures 1 and 2, respectively.
- the arterial line section 301 and the venous line section 305 can be part of a blood tubing set or form this.
- FIG. 2 shows a schematically simplified part of the blood treatment device 100 of FIG. 1, namely the part to the right of the dashed line A, during the method according to the invention.
- FIG. 2 shows a schematically simplified part of the blood treatment device 100 of FIG. 1, namely the part to the right of the dashed line A, during the method according to the invention.
- FIG. 2 shows a schematically simplified part of the blood treatment device 100 of FIG. 1, namely the part to the right of the dashed line A, during the method according to the invention.
- the method according to the invention leads to a reversal of flow in the venous line section 305, as indicated by the direction of the arrows and arrowheads which is in the opposite direction in comparison to FIG. 1, to prevent or noticeably reduce the flow between the patient and the venous hose clamp 306 and for liquid to pass from the blood chamber 303b into the dialysis liquid chamber 303a, as also indicated by arrows.
- Fig. 3 schematically shows the sequence of the method according to the invention.
- the blood treatment device 100 which is to be controlled using the method according to the invention, has a blood pump 101, an air bubble detector 315 and a pump for conveying dialysis liquid and/or dialysate on the hydraulic side of the blood treatment device 100 (see Fig. 1 and Fig. 2).
- the method is intended to be performed during an extracorporeal blood treatment session, ie intradialytically.
- the blood treatment device 100 is connected to an extracorporeal blood circuit 300 and to a blood filter 303 .
- the blood filter 303 in turn has a semi-permeable membrane 303c.
- the method optionally includes as M1 the step of detecting air bubbles or air inclusions in the extracorporeal blood circuit 300 or detecting an air bubble alarm.
- the air bubbles or air inclusions can be detected using the air bubble detector 315 .
- this can be suitably configured to trigger an air or gas bubble alarm as a result of the detection of air bubbles.
- step M1 does not belong to the method according to the invention, but is regarded as a prerequisite for carrying out the same.
- Method step M2 represents a stopping of the blood pump 101 or, alternatively, a reduction in the pumping capacity provided immediately before air bubbles are detected.
- the optional method step M3 stands for a complete or partial closing of the venous hose clamp 306.
- Method step M5 represents an opening of the venous hose clamp 306 when the negative transmembrane pressure P TM has already been generated while maintaining a negative transmembrane pressure PTM or with a negative transmembrane pressure PTM.
- Hose clamp 306 is opened when a negative minimum transmembrane pressure P TM-min has been determined, for example by means of at least one pressure sensor PS4 of blood treatment device 100.
- the pressure sensor PS3 (venous sensor) or the pressure sensor PS2 are used to evaluate the pressure situation.
- the determined pressures can be monitored in order to detect a drop in pressure and to open the venous tube clamp 306 accordingly.
- the operating pressure during treatment is mostly around 320 mmHg for PS3 and around 300 mmHg for PS2.
- a (transmembrane) plasma water transfer takes place via the membrane and the blood is hemoconcentrated in the dialyzer.
- the volume pumped into the hydraulic system is replaced by the blood flowing out of the patient via the venous hose system in the opposite direction to the usual flow.
- the air bubbles or air pockets are conveyed back into the venous air separation chamber and separated there, for example to the environment.
- a negative transmembrane pressure PTM is generated by the pump, while an optional substituate pump 111 of
- Blood treatment device 100 is stopped or not promoting.
- Method step M6 stands for ending the generation or maintenance of the negative transmembrane pressure PTM as soon as a predetermined negative transmembrane pressure PTM, which is, for example, in the range between -300 mmHg and -500 mmHg, is reached or by means of the generated transmembrane pressure PTM , or due to this Volume of at least 30 to 60 ml of blood in the direction of an arterial needle or a venous air separation chamber 329 was conveyed.
- a predetermined negative transmembrane pressure PTM which is, for example, in the range between -300 mmHg and -500 mmHg, is reached or by means of the generated transmembrane pressure PTM , or due to this Volume of at least 30 to 60 ml of blood in the direction of an arterial needle or a venous air separation chamber 329 was conveyed.
- Air bubble detector 315 no longer detects air bubbles or air pockets and/or no air bubble alarm is present.
- Blood treatment device 100 can be the ultrafiltration pump 131, for example.
- Reference List
- PSI arterial pressure sensor (optional)
- PS2 arterial pressure sensor (optional)
- PS4 pressure sensor for measuring the filtrate pressure (optional) PTM negative transmembrane pressure
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Pulmonology (AREA)
- External Artificial Organs (AREA)
- Electrotherapy Devices (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102021110331.2A DE102021110331A1 (de) | 2021-04-22 | 2021-04-22 | Verfahren zum Steuern einer Blutbehandlungsvorrichtung, und Vorrichtungen |
PCT/EP2022/060501 WO2022223669A1 (de) | 2021-04-22 | 2022-04-21 | Verfahren zum steuern einer blutbehandlungsvorrichtung, und vorrichtungen |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4326361A1 true EP4326361A1 (de) | 2024-02-28 |
Family
ID=81748424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22724073.6A Pending EP4326361A1 (de) | 2021-04-22 | 2022-04-21 | Verfahren zum steuern einer blutbehandlungsvorrichtung, und vorrichtungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US20240207494A1 (zh) |
EP (1) | EP4326361A1 (zh) |
JP (1) | JP2024514600A (zh) |
KR (1) | KR20230175224A (zh) |
CN (1) | CN117202948A (zh) |
AU (1) | AU2022260476A1 (zh) |
CA (1) | CA3217042A1 (zh) |
DE (1) | DE102021110331A1 (zh) |
WO (1) | WO2022223669A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102022119819A1 (de) | 2022-08-05 | 2024-02-08 | Fresenius Medical Care AG & Co. KGaA | Blutbehandlungsvorrichtung |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252213A (en) | 1989-06-20 | 1993-10-12 | University Of Washington | Dry dialysate composition |
US7615028B2 (en) | 2004-12-03 | 2009-11-10 | Chf Solutions Inc. | Extracorporeal blood treatment and system having reversible blood pumps |
US20120065482A1 (en) | 2005-04-08 | 2012-03-15 | Mark Ries Robinson | Determination of blood pump system performance and sample dilution using a property of fluid being transported |
DE102011110472A1 (de) * | 2011-07-29 | 2013-01-31 | Fresenius Medical Care Deutschland Gmbh | Verfahren sowie Vorrichtungen zum Ablösen von Gasansammlungen von einem Gerinnselfänger eines extrakorporalen Blutkreislaufs |
US9173987B2 (en) | 2013-02-01 | 2015-11-03 | Medtronic, Inc. | Degassing module for a controlled compliant flow path |
DE102016107026A1 (de) * | 2016-04-15 | 2017-10-19 | B. Braun Avitum Ag | Verfahren zur Entleerung eines Geräts zur extrakorporalen Blutbehandlung |
-
2021
- 2021-04-22 DE DE102021110331.2A patent/DE102021110331A1/de active Pending
-
2022
- 2022-04-21 AU AU2022260476A patent/AU2022260476A1/en active Pending
- 2022-04-21 CN CN202280029985.3A patent/CN117202948A/zh active Pending
- 2022-04-21 US US18/556,201 patent/US20240207494A1/en active Pending
- 2022-04-21 JP JP2023562733A patent/JP2024514600A/ja active Pending
- 2022-04-21 KR KR1020237038254A patent/KR20230175224A/ko unknown
- 2022-04-21 EP EP22724073.6A patent/EP4326361A1/de active Pending
- 2022-04-21 CA CA3217042A patent/CA3217042A1/en active Pending
- 2022-04-21 WO PCT/EP2022/060501 patent/WO2022223669A1/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022223669A1 (de) | 2022-10-27 |
CA3217042A1 (en) | 2022-10-27 |
AU2022260476A1 (en) | 2023-10-12 |
CN117202948A (zh) | 2023-12-08 |
KR20230175224A (ko) | 2023-12-29 |
DE102021110331A1 (de) | 2022-10-27 |
JP2024514600A (ja) | 2024-04-02 |
US20240207494A1 (en) | 2024-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60037408T3 (de) | Vorrichtung zur Hämodialyse | |
EP2337593B1 (de) | Verfahren und vorrichtung zur überprüfung der zufuhr von substitutionsflüssigkeit stromauf oder stromab eines dialysators oder filters | |
EP2249898B1 (de) | Verfahren zum bestimmen des anteils der rezirkulation in einer fistel und/oder der kardiopulmonalen rezirkulation an der summe von fistelrezirkulation und kardiopulmonaler rezirkulation | |
EP1356836B1 (de) | Vorrichtung zur extrakorporalen Blutbehandlung | |
EP2337592B1 (de) | Vorrichtung zur extrakorporalen blutbehandlung im einnadel-betrieb | |
DE4240681C2 (de) | Vorrichtung zur Hämodialyse ohne Antikoagulation | |
DE3313421A1 (de) | Vorrichtung zur extrakorporalen reinigung von blut | |
WO2014044365A1 (de) | Vorrichtung und verfahren zur erkennung der rezirkulation während einer extrakorporalen blutbehandlung | |
EP3041525B1 (de) | Medizinische vorrichtung mit einer steuervorrichtung zum beeinflussen des drucks innerhalb eines heizbeutels während einer medizinischen behandlung | |
WO2009080258A1 (de) | Verfahren und vorrichtung zur bestimmung des transmembrandrucks bei einer extrakorporalen blutbehandlung | |
WO2018054901A1 (de) | Verfahren zum entfernen von blut aus einem extrakorporalen blutkreislauf nach beendigung einer blutbehandlungssitzung, steuerungs- und regelungseinrichtung sowie behandlungsvorrichtung zum durchführen desselben | |
WO2022223669A1 (de) | Verfahren zum steuern einer blutbehandlungsvorrichtung, und vorrichtungen | |
EP3478335B1 (de) | Blutbehandlungsvorrichtung zur bluterkennung in einer dialysierflüssigkeitsabführleitung | |
EP3820542B1 (de) | Steuerungs- und/oder regelungseinrichtung zum entfernen von fluid aus einem blutfilter | |
WO2019197314A1 (de) | Blutschlauchsatz, steuer- oder regelvorrichtung, blutbehandlungsvorrichtung und verfahren für die single needle-behandlung | |
EP2988661B1 (de) | Steuereinheit und verfahren zur bestimmung eines drucks in einem blutgefäss, insbesondere in einer arteriovenösen fistel | |
DE102021132723A1 (de) | Blutbehandlungsvorrichtung mit gekoppelter Blutpumpe und Drucklufteinrichtung | |
WO2022128796A1 (de) | Kurzschlussleitung, medizintechnische behandlungsvorrichtung, sowie verfahren | |
WO2021151932A1 (de) | Verfahren und vorrichtungen zum festlegen eines zeitpunkts zum erheben von druckmesswerten | |
DE102023104402A1 (de) | Blutbehandlungsvorrichtung mit Kompensation von Änderungen der Umgebungstemperatur | |
WO2024175661A1 (de) | Blutbehandlungsvorrichtung mit kompensation von aenderungen der umgebungstemperatur | |
WO2023110986A1 (de) | Blutbehandlungsvorrichtung mit heizungsregelung | |
DE102022102164A1 (de) | Blutbehandlungsvorrichtung mit Schwingvorrichtung | |
EP3797804A1 (de) | Blutbehandlungsvorrichtung mit automatischer substitutionsvolumenkompensation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20231122 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |